Cart
sales@molnova.com
CDK4-IN-1
CAS No. 1256963-02-6
CDK4-IN-1( LEE011 analog | CDK4-IN-1 | CDK4IN-1 | CDK4-IN1 )
Catalog No. M11055 CAS No. 1256963-02-6
CDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCDK4-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM.
-
DescriptionCDK4 inhibitor is a novel and specific CDK4/Cyclin D1 inhibitor with an IC50 of 10 nM; 1500 and 500 fold than CDK1/Cyclin B (IC50>15 uM) and CDK2/Cyclin A (IC50=5.265 uM) respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsLEE011 analog | CDK4-IN-1 | CDK4IN-1 | CDK4-IN1
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK4| Cyclin D1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1256963-02-6
-
Formula Weight440.97
-
Molecular FormulaC22H29ClN8
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESCN(C1CCN(C2=CN=C(NC3=NC=CC(C4=C(C(C)C)NN=C4Cl)=N3)C=C2)CC1)C
-
Chemical Name4-(3-Chloro-5-propan-2-yl-1H-pyrazol-4-yl)-N-[5-[4-(dimethylamino)piperidin-1-yl]pyridin-2-yl]pyrimidin-2-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cho YS, et al. J Med Chem. 2010 Nov 25;53(22):7938-57.
molnova catalog
related products
-
PCI-27483
PCI 27483 is an activated coagulation factor VIIa inhibitor with antithrombotic effects in a baboon model of arterial thrombosis.
-
JSH-150
JSH-150 (JSH150) is a potent, highly selective inhibitor of CDK9 kinase with IC50 of 1 nM in the biochemical assays, displays 300-10000-fold selectivity over other CDK kinase family members (CDK7 IC50=1.72 uM).
-
VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
